AI Drug Discovery

AI Drug Discovery

AI Drug Discovery

Building Better Medicines with AI

With 192 compounds and 67 validated assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology, we're innovating at the intersection of data science, biology and drug development

With 192 compounds and 67 validated assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology, we're innovating at the intersection of data science, biology and drug development

Featured In

PartnershipS

Validated by Leading Scientists at Top Academic and Corporate Labs

We recognize that no one business can revolutionize the way medicines are discovered and developed on their own. We want to leverage our technology and expertise in partnership with the world’s leading researchers and scientists.

Model Medicines

Humanity Can’t Wait Decades, Which is Why We Focus on Days

We are focused on discovering drugs with best-in-class potential against rigorous target product profiles, not merely creating thousands of hits that never reach the clinic.

With GALILEO™, we've discovered 192 compounds and advanced 67 assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology. Our data was validated by preeminent researchers and scientists at premier academic and corporate laboratories.